Literature DB >> 30956007

Insulin-like growth factor 2 regulates the proliferation and differentiation of rat adipose-derived stromal cells via IGF-1R and IR.

Chao Wang1, Xiaoming Li2, Hongxing Dang1, Ping Liu2, B O Zhang2, Feng Xu3.   

Abstract

BACKGROUND: Insulin-like growth factor 2 (IGF2), an essential component of the stem cell niche, has been reported to modulate the proliferation and differentiation of stem cells. Previously, a continuous expression of IGF2 in tissues was reported to maintain the self-renewal ability of several types of stem cells. Therefore, in this study, we investigated the expression of IGF2 in adipose tissues and explored the effects of IGF2 on adipose-derived stromal cells (ADSCs) in vitro.
METHODS: The expression pattern of IGF2 in rat adipose tissues was determined by gene expression and protein analyses. The effect of IGF2 on proliferation, stemness-related marker expression and adipogenic and osteogenic differentiation was systematically investigated. Furthermore, antagonists of IGF2-specific receptors-namely, BMS-754807 and picropodophyllin-were added to explore the underlying signal transduction mechanisms.
RESULTS: IGF2 levels displayed a tendency to decrease with age in rat adipose tissues. After the addition of IGF2, isolated ADSCs displayed higher proliferation and expression of the stemness-related markers NANOG, OCT4 and SOX2 and greater differentiation potential to adipocytes and osteoblasts. Additionally, both type 1 insulin-like growth factor receptor (IGF-1R) and insulin receptor (IR) participated in the IGF2-mediated promotion of stemness in ADSCs.
CONCLUSIONS: Our findings indicate that IGF2 could enhance the stemness of rat ADSCs via IGF-1R and IR and may highlight an effective method for the expansion of ADSCs for clinical application.
Copyright © 2018 International Society for Cell and Gene Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adipose-derived stromal cells (ADSCs); insulin-like growth factor 2 (IGF2); multipotency; stem cell therapy

Mesh:

Substances:

Year:  2019        PMID: 30956007     DOI: 10.1016/j.jcyt.2018.11.010

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  4 in total

1.  Bone Marrow Adiposity in Models of Radiation- and Aging-Related Bone Loss Is Dependent on Cellular Senescence.

Authors:  Abhishek Chandra; Anthony B Lagnado; Joshua N Farr; Megan Schleusner; David G Monroe; Dominik Saul; João F Passos; Sundeep Khosla; Robert J Pignolo
Journal:  J Bone Miner Res       Date:  2022-03-29       Impact factor: 6.390

2.  Human Adipose Stem Cells (hASCs) Grown on Biodegradable Microcarriers in Serum- and Xeno-Free Medium Preserve Their Undifferentiated Status.

Authors:  Francesco Muoio; Stefano Panella; Valentin Jossen; Matias Lindner; Yves Harder; Michele Müller; Regine Eibl; Tiziano Tallone
Journal:  J Funct Biomater       Date:  2021-04-16

3.  Deciphering the Emerging Roles of Adipocytes and Adipose-Derived Stem Cells in Fat Transplantation.

Authors:  Yi Yi; Weijie Hu; Chongru Zhao; Min Wu; Hong Zeng; Mingchen Xiong; Wenchang Lv; Yiping Wu; Qi Zhang
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 4.  Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine.

Authors:  Syuan-Ling Lin; Chih-Yang Lin; Wei Lee; Chiao-Fang Teng; Woei-Cherng Shyu; Long-Bin Jeng
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.